We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Going it alone.
- Abstract
The article focuses on the success if several biotech company drugs launches in 2014 including biopharmaceutical companies ThromboGenics NV, Acorda Therapeutics Inc., and Ariad Pharmaceuticals Inc. Topics include the U.S. Food and Drug Administration's (FDA) approval on the drug Jetrea (ocriplasmin) launched by ThromboGenics NV, the launching and sales force timing as challenge for go-it-alone biotechs, and the commercial executives for go-it-alone biotechs recruited from larger firms.
- Subjects
PHARMACEUTICAL biotechnology; PRODUCT launches; THROMBOGENICS NV; ACORDA Therapeutics Inc.; ARIAD Pharmaceuticals Inc.
- Publication
Nature Biotechnology, 2014, Vol 32, Issue 5, p411
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt.2896